Melanoma Research Today is a free monthly online journal that collates and summarizes the latest research about Melanoma, including details on identification, causes, prevention, treatment.

Volume 2 (2005), Issue 1 (January)

1. Carnosol inhibits the invasion of B16/F10 mouse melanoma cells by suppressing metalloproteinase-9 through down-regulating nuclear factor-kappa B and c-Jun.
   Biochem Pharmacol, 69(2): 221-32. [Abstract] [Full-text]
2. In vitro and in vivo tumor growth inhibition by a p16-mimicking peptide in p16INK4A-defective, pRb-positive human melanoma cells.
   J Cell Physiol, 202(3): 922-8. [Abstract] [Full-text]
3. Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function.
   J Exp Med, 201(1): 139-48. [Abstract] [Full-text]
4. The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma: IV. Ten-year mortality findings and prognostic factors. COMS report number 24.
   Am J Ophthalmol, 138(6): 936-51. [Abstract] [Full-text]
5. Redirecting human CD4+ T lymphocytes to the MHC class I-restricted melanoma antigen MAGE-A1 by TCR alphabeta gene transfer requires CD8alpha.
   Gene Ther, 12(2): 140-6. [Abstract] [Full-text]
6. Augmentation of the migratory ability of DC-based vaccine into regional lymph nodes by efficient CCR7 gene transduction.
   Gene Ther, 12(2): 129-39. [Abstract] [Full-text]
7. Sphingosine kinase activity counteracts ceramide-mediated cell death in human melanoma cells: role of Bcl-2 expression.
   Oncogene, 24(1): 178-87. [Abstract] [Full-text]
8. Asiatic acid induces apoptosis in SK-MEL-2 human melanoma cells.
   Cancer Lett, 218(1): 81-90. [Abstract] [Full-text]
9. Polysaccharides isolated from Phellinus gilvus inhibit melanoma growth in mice.
   Cancer Lett, 218(1): 43-52. [Abstract] [Full-text]
10. Major amputation for intractable extremity melanoma after failure of isolated limb perfusion.
    Eur J Surg Oncol, 31(1): 95-9. [Abstract] [Full-text]
11. Extra nodal growth as a prognostic factor in malignant melanoma.
    Eur J Surg Oncol, 31(1): 88-94. [Abstract] [Full-text]
12. Immunotherapy of melanoma targeting human high molecular weight melanoma-associated antigen: potential role of nonimmunological mechanisms.
    Ann N Y Acad Sci, 1028: 340-50. [Abstract] [Full-text]
13. Sentinel lymph node biopsy in head and neck cancer.
    Otolaryngol Clin North Am, 38(1): 145-60, ix-x. [Abstract] [Full-text]
14. Evaluation of extensive initial staging procedure in intermediate/high-risk melanoma patients.
    J Eur Acad Dermatol Venereol, 19(1): 66-73. [Abstract] [Full-text]
15. Decreased expression of Apaf-1 with progression of melanoma.
    Pigment Cell Res, 18(1): 59-62. [Abstract] [Full-text]
16. MAGE-A3 is a frequent tumor antigen of metastasized melanoma.
    Arch Dermatol Res, 296(7): 314-9. [Abstract] [Full-text]
17. Phase I/II study of immunotherapy with T-cell peptide epitopes in patients with stage IV melanoma.
    Cancer Immunol Immunother, 54(3): 208-18. [Abstract] [Full-text]
18. Malignant melanoma and HIV infection -- aggressive course despite immune reconstitution.
    Onkologie, 28(1): 35-7. [Abstract] [Full-text]
19. Postoperative radiotherapy for primary mucosal melanoma of the head and neck.
    Cancer, 103(2): 313-9. [Abstract] [Full-text]
20. Small bowel intussusception due to metastatic malignant melanoma. A case report.
    Tech Coloproctol, 8: s141-3. [Abstract] [Full-text]
21. Identifying risk factors for complications following sentinel lymph node biopsy for melanoma.
    Arch Surg, 140(1): 85-9. [Abstract] [Full-text]
22. Shape discrimination by total curvature, with a view to cancer diagnostics.
    J Microsc, 217: 49-59. [Abstract] [Full-text]
23. Selective induction of apoptosis in melanoma cells by tyrosinase promoter-controlled CD95 ligand overexpression.
    J Invest Dermatol, 124(1): 221-8. [Abstract] [Full-text]
24. Epitope-specific antibody response to Mel-CAM induced by mimotope immunization.
    J Invest Dermatol, 124(1): 125-31. [Abstract] [Full-text]
25. Contrasting frequencies of antitumor and anti-vaccine T cells in metastases of a melanoma patient vaccinated with a MAGE tumor antigen.
    J Exp Med, 201(2): 249-57. [Abstract] [Full-text]
26. High frequency of antitumor T cells in the blood of melanoma patients before and after vaccination with tumor antigens.
    J Exp Med, 201(2): 241-8. [Abstract] [Full-text]
27. Thick melanoma: the challenge persists.
    Br J Dermatol, 152(1): 104-9. [Abstract] [Full-text]
28. Surveillance of patients at high risk for cutaneous malignant melanoma using digital dermoscopy.
    Br J Dermatol, 152(1): 87-92. [Abstract] [Full-text]
29. Is ultrasound lymph node examination superior to clinical examination in melanoma follow-up? A monocentre cohort study of 373 patients.
    Br J Dermatol, 152(1): 66-70. [Abstract] [Full-text]
30. PD-1 blockade inhibits hematogenous spread of poorly immunogenic tumor cells by enhanced recruitment of effector T cells.
    Int Immunol, 17(2): 133-44. [Abstract] [Full-text]
31. Bypassing tumor-associated immune suppression with recombinant adenovirus constructs expressing membrane bound or secreted GITR-L.
    Cancer Gene Ther, 12(2): 198-205. [Abstract] [Full-text]
32. Systemic administration of attenuated Salmonella choleraesuis carrying thrombospondin-1 gene leads to tumor-specific transgene expression, delayed tumor growth and prolonged survival in the murine melanoma model.
    Cancer Gene Ther, 12(2): 175-84. [Abstract] [Full-text]
33. Employment of microarray analysis to characterize biologic differences associated with tropism-modified adenoviral vectors: utilization of non-native cellular entry pathways.
    Cancer Gene Ther, 12(2): 162-74. [Abstract] [Full-text]
34. Radiobiological investigation of dose-rate effects in intensity-modulated radiation therapy.
    Strahlenther Onkol, 181(1): 42-8. [Abstract] [Full-text]
35. Lithotripter shockwave-induced enhancement of mouse melanoma lung metastasis: dependence on cavitation nucleation.
    J Endourol, 18(9): 925-9. [Abstract] [Full-text]
36. Inhibition of B16 mouse melanoma cell growth and induction of apoptotic cell death with 8-chloroadenosine-3',5'-monophosphate and tiazofurin.
    Ann N Y Acad Sci, 1030: 384-92. [Abstract] [Full-text]
37. Endogenous oxidative stress induces distinct redox forms of tumor necrosis factor receptor-1 in melanoma cells.
    Ann N Y Acad Sci, 1030: 62-8. [Abstract] [Full-text]
38. Prognostic implications of multiple lymphatic basin drainage in patients with truncal melanoma.
    J Clin Oncol, 23(3): 518-24. [Abstract] [Full-text]
39. Combined treatment with EGFR inhibitors and arsenite upregulated apoptosis in human EGFR-positive melanomas: a role of suppression of the PI3K-AKT pathway.
    Oncogene, 24(4): 616-26. [Abstract] [Full-text]
40. Protective effect of quercetin and luteolin in human melanoma HMB-2 cells.
    Mutat Res, 565(2): 105-12. [Abstract] [Full-text]
41. Possible histopathologic correlates of dermoscopic features in pigmented melanocytic lesions identified by means of optical coherence tomography.
    Exp Dermatol, 14(1): 56-9. [Abstract] [Full-text]
42. High-dose continuous infusion plus pulse interleukin-2 and famotidine in melanoma.
    Cancer Biother Radiopharm, 19(6): 770-5. [Abstract] [Full-text]
43. Individualized synthetic peptide vaccines with GM-CSF in locally advanced melanoma patients.
    Cancer Biother Radiopharm, 19(6): 758-63. [Abstract] [Full-text]
44. Continuous infusion interleukin-2 and antihistamines in melanoma: a retrospective review showing activity of this combination.
    Cancer Biother Radiopharm, 19(6): 754-7. [Abstract] [Full-text]
45. Evaluation of germline CDKN2A, ARF, CDK4, PTEN, and BRAF alterations in atypical mole syndrome.
    Clin Exp Dermatol, 30(1): 68-70. [Abstract] [Full-text]
46. Pigmented seborrheic keratoses of the vulva clinically mimicking a malignant melanoma: a clinical, dermoscopic-pathologic case study.
    Clin Exp Dermatol, 30(1): 17-9. [Abstract] [Full-text]
47. Wavelet analysis of cutaneous blood flow in melanocytic skin lesions.
    J Vasc Res, 42(1): 38-46. [Abstract] [Full-text]
48. Actin-depolymerizing factor and cofilin-1 play overlapping roles in promoting rapid F-actin depolymerization in mammalian nonmuscle cells.
    Mol Biol Cell, 16(2): 649-64. [Abstract] [Full-text]
49. Inhibitory effect of Boerhaavia diffusa on experimental metastasis by B16F10 melanoma in C57BL/6 mice.
    Life Sci, 76(12): 1339-49. [Abstract] [Full-text]
50. Evaluation of a KTP (potassium-titanyl-phosphate) 532 nm laser for endovaporization of choroidal melanomas.
    Lasers Surg Med, 36(1): 57-64. [Abstract] [Full-text]
51. Abnormal cell cycle regulation in primary human uveal melanoma cultures.
    J Cell Biochem, 93(4): 708-20. [Abstract] [Full-text]
52. Novel melanoma antigen, FCRL/FREB, identified by cDNA profile comparison using DNA chip are immunogenic in multiple melanoma patients.
    Int J Cancer, 114(2): 283-90. [Abstract] [Full-text]
53. Dominant B cell epitope from NY-ESO-1 recognized by sera from a wide spectrum of cancer patients: implications as a potential biomarker.
    Int J Cancer, 114(2): 268-73. [Abstract] [Full-text]
54. International uveal melanoma incidence trends in view of a decreasing proportion of morphological verification.
    Int J Cancer, 114(1): 114-23. [Abstract] [Full-text]
55. SEREX identification of new tumor antigens linked to melanoma-associated retinopathy.
    Int J Cancer, 114(1): 88-93. [Abstract] [Full-text]
56. Ursolic acid induces apoptosis through mitochondrial intrinsic pathway and caspase-3 activation in M4Beu melanoma cells.
    Int J Cancer, 114(1): 1-11. [Abstract] [Full-text]
57. No association between three xeroderma pigmentosum group C and one group G gene polymorphisms and risk of cutaneous melanoma.
    Eur J Hum Genet, 13(2): 253-5. [Abstract] [Full-text]
58. Supercharged reverse-flow sural flap: a new modification increasing the reliability of the flap.
    Microsurgery, 25(1): 36-43. [Abstract] [Full-text]
59. Genomic alterations in primary cutaneous melanomas detected by metaphase comparative genomic hybridization with laser capture or manual microdissection: 6p gains may predict poor outcome.
    Cancer Genet Cytogenet, 157(1): 1-11. [Abstract] [Full-text]
60. Distinction of desmoplastic melanoma from non-desmoplastic melanoma by gene expression profiling.
    J Invest Dermatol, 124(2): 412-8. [Abstract] [Full-text]
61. Glycyrrhizin induces melanogenesis by elevating a cAMP level in b16 melanoma cells.
    J Invest Dermatol, 124(2): 405-11. [Abstract] [Full-text]
62. Gene expression profile changes between melanoma metastases and their daughter cell lines: implication for vaccination protocols.
    J Invest Dermatol, 124(2): 401-4. [Abstract] [Full-text]
63. Autoimmunity in a phase I trial of a fully human anti-cytotoxic T-lymphocyte antigen-4 monoclonal antibody with multiple melanoma peptides and Montanide ISA 51 for patients with resected stages III and IV melanoma.
    J Clin Oncol, 23(4): 741-50. [Abstract] [Full-text]

© 2004-2008 Melanoma Research Today. All Rights Reserved.